© 2000 American Heart Association, Inc.
Vascular Biology |
Endoglin Is Overexpressed After Arterial Injury and Is Required for Transforming Growth Factor-ß–Induced Inhibition of Smooth Muscle Cell Migration
From the Division of Cardiology (X.M., M.Lab., J.G., H.M., E.O.) and the Division of Cardiovascular Surgery (W.J.K.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada, and the Cancer and Blood Program (M.Let.), The Hospital for Sick Children and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Correspondence to Edward R. O’Brien, MD, FRCPC, FACC, Division of Cardiology, Vascular Biology Laboratory, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario, Canada K1Y 4W7. E-mail eobrien{at}ottawaheart.ca
Abstract—Endoglin is a homodimeric membrane glycoprotein primarily expressed on endothelial cells. In association with transforming growth factor (TGF)-ß receptors I and II, it can bind TGF-ß1 and -ß3 and form a functional receptor complex. There is increasing evidence that endoglin can modulate the cellular response to TGF-ß, a factor implicated in vascular lesion formation in human and experimental models. The purpose of this study was to analyze the expression of endoglin in normal and balloon-injured porcine coronary arteries and in normal and atherosclerotic human coronary arteries and to determine its ability to mediate the effects of TGF-ß on the migration of vascular smooth muscle cells (SMCs). In normal porcine coronary arteries, endoglin was of low abundance and was found primarily on endothelial cells and adventitial fibroblasts, as well as on a minority of medial SMCs. On days 3, 7, and 14 after angioplasty, endoglin was present not only on endothelial cells but also on adventitial myofibroblasts and medial SMCs of porcine coronary arteries. By day 28, few or no cells expressed endoglin. In situ hybridization revealed that endoglin mRNA expression appeared to be highest in endothelial cells on days 3, 7, and 14 days after injury and absent thereafter. With a second balloon injury, a similar pattern of endoglin protein and mRNA expression was observed. In human vascular tissue, endoglin immunolabeling was higher in endarterectomy specimens removed from diseased coronary arteries than in normal internal mammary arteries. In vitro, antisense oligonucleotides to endoglin decreased its expression and antagonized the TGF-ß–mediated inhibition of human and porcine SMC migration. In summary, upregulation of endoglin occurs during arterial repair and in established atherosclerotic plaques and may be required for modulation of SMC migration by TGF-ß.
Key Words: endoglin • transforming growth factor-ß • receptors • smooth muscle cells • endothelial cells
This article has been cited by other articles:
 |
|
 |
|
  Y. Yinon, O. Nevo, J. Xu, A. Many, A. Rolfo, T. Todros, M. Post, and I. Caniggia Severe Intrauterine Growth Restriction Pregnancies Have Increased Placental Endoglin Levels: Hypoxic Regulation via Transforming Growth Factor- 3 Am. J. Pathol., January 1, 2008; 172(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Meng, A. Lux, A. Holloschi, J. Li, J. M. X. Hughes, T. Foerg, J. E. G. McCarthy, A. M. Heagerty, P. Kioschis, M. Hafner, et al. Identification of Tctex2beta, a Novel Dynein Light Chain Family Member That Interacts with Different Transforming Growth Factor-beta Receptors J. Biol. Chem., December 1, 2006; 281(48): 37069 - 37080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Koleva, B. A. Conley, D. Romero, K. S. Riley, J. A. Marto, A. Lux, and C. P. H. Vary Endoglin Structure and Function: DETERMINANTS OF ENDOGLIN PHOSPHORYLATION BY TRANSFORMING GROWTH FACTOR-beta RECEPTORS J. Biol. Chem., September 1, 2006; 281(35): 25110 - 25123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Docherty, J. M. Lopez-Novoa, M. Arevalo, A. Duwel, A. Rodriguez-Pena, F. Perez-Barriocanal, C. Bernabeu, and N. Eleno Endoglin regulates renal ischaemia-reperfusion injury Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2106 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Charalambous, L. B. Pen, Y. S. Su, J. Milan, T. C. Chen, and F. M. Hofman Interleukin-8 Differentially Regulates Migration of Tumor-Associated and Normal Human Brain Endothelial Cells Cancer Res., November 15, 2005; 65(22): 10347 - 10354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Pece-Barbara, S. Vera, K. Kathirkamathamby, S. Liebner, G. M. Di Guglielmo, E. Dejana, J. L. Wrana, and M. Letarte Endoglin Null Endothelial Cells Proliferate Faster and Are More Responsive to Transforming Growth Factor {beta}1 with Higher Affinity Receptors and an Activated Alk1 Pathway J. Biol. Chem., July 29, 2005; 280(30): 27800 - 27808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sanz-Rodriguez, M. Guerrero-Esteo, L.-M. Botella, D. Banville, C. P. H. Vary, and C. Bernabeu Endoglin Regulates Cytoskeletal Organization through Binding to ZRP-1, a Member of the Lim Family of Proteins J. Biol. Chem., July 30, 2004; 279(31): 32858 - 32868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Conley, R. Koleva, J. D. Smith, D. Kacer, D. Zhang, C. Bernabeu, and C. P. H. Vary Endoglin Controls Cell Migration and Composition of Focal Adhesions: FUNCTION OF THE CYTOSOLIC DOMAIN J. Biol. Chem., June 25, 2004; 279(26): 27440 - 27449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Berg, M Porteous, D Reinhardt, C Gallione, S Holloway, T Umasunthar, A Lux, W McKinnon, D Marchuk, and A Guttmacher Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations J. Med. Genet., August 1, 2003; 40(8): 585 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Mueller, C. Ma, J. A. Lederer, and D. L. Perkins Differentiation of stress, metabolism, communication, and defense responses following transplantation J. Leukoc. Biol., March 1, 2003; 73(3): 379 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Botella, T. Sanchez-Elsner, F. Sanz-Rodriguez, S. Kojima, J. Shimada, M. Guerrero-Esteo, M. P. Cooreman, V. Ratziu, C. Langa, C. P. H. Vary, et al. Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury Blood, December 1, 2002; 100(12): 4001 - 4010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Cho, A. Bourdeau, M. Letarte, and J. C. Zuniga-Pflucker Expression and function of CD105 during the onset of hematopoiesis from Flk1+ precursors Blood, December 15, 2001; 98(13): 3635 - 3642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant Circ. Res., December 7, 2001; 89(12): 1111 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, D. Li, T. Saldeen, and J. L. Mehta Transforming Growth Factor-{beta}1 Modulates Oxidatively Modified LDL-Induced Expression of Adhesion Molecules: Role of LOX-1 Circ. Res., December 7, 2001; 89(12): 1155 - 1160. [Abstract] [Full Text] [PDF]
|
|